Trials / Completed
CompletedNCT02876237
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer
Patient Over 75 Years With Prostate Cancer: Geriatric Determinants of General Repercussion of Radiotherapy With Curative Intent
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 230 (actual)
- Sponsor
- Institut Cancerologie de l'Ouest · Academic / Other
- Sex
- Male
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose to carry out a prospective analysis of physical impact, psychological, cognitive and social of radiotherapy in all patients over 75 years bearer of localized prostate cancer with an indication of curative radiotherapy. This standardized geriatric assessment will collect social information, functional, sensory, cognitive, emotional, motor, nutritional, and medical related to comorbidities . The quality of life of patients will be evaluated by the QLQ C30 (Quality of Life Questionnaire) European Organisation for Research and Treatment of Cancer (EORTC) before starting treatment, at the end of radiotherapy (2 months) and at 6 months. This short follow-up period seems appropriate in this elderly population and will allow an answer within 2 years to the problem raised in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | geriatric assessment and quality of life | Included patient must have a geriatric assessment before radiotherapy and 6 months later. This standardized geriatric assessment will collect social information, functional, sensory, cognitive, emotional, motor, nutritional, and medical related to comorbidities . Patient must complete quality of life questionnaire before radiotherapy then 2 and 6 months later. |
| RADIATION | Radiotherapy | standard radiotherapy |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-02-01
- Completion
- 2017-08-01
- First posted
- 2016-08-23
- Last updated
- 2018-05-31
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02876237. Inclusion in this directory is not an endorsement.